It is known that IFN-γ can directly inhibit breast cancer by restoring ICI-induced apoptosis in breast cancer cells that have acquired resistance to this antiestrogen [112], and the combination of anti-growth factor receptor MAb and cytokines such as IFN-γ may be useful in the treatment of breast cancer [113]. The gene discussed is IFNG; the disease is breast carcinoma.